About 19 results
Open links in new tab
  1. High Intensity Focused Ultrasound (HIFU) - Mount Sinai Health …

    High-Intensity Focused Ultrasound or HIFU is a non-invasive heating procedure for treating localized prostate cancer.

  2. Active Surveillance | Mount Sinai - New York

    Active surveillance is most appropriate for you medically if: You aren’t experiencing any symptoms You have a slow-growing cancer (Gleason score of less than 6) Your cancer is small (cannot …

  3. Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate …

    Jan 16, 2024 · Summary: This is a partially blinded randomized controlled phase II pilot study comparing Poly-ICLC (Hiltonol®) treatment vs no treatment, for prostate cancer participants …

  4. Turning 18 Months into 18 Years | Mount Sinai - New York

    When Bill was first informed of his advanced disease (Gleason Total Score 9, Grade T-3A) in 1995, the recommendation to go on hormone therapy with Lupron. In addition, Bill made …

  5. Healthcare & Patient Services | Mount Sinai - New York

    Mount Sinai Health System offers patients the full range of clinical care specialties and treatments, as well as a vast network of facilities.

  6. Menon precision prostatectomy (MPP) is a novel surgical approach developed by Mani Menon, MD, and his team that preserves nerve function a er prostatectomy, allowing earlier return of …

  7. Pathology Test Uses Artificial Intelligence to Predict Prostate …

    Oct 2, 2018 · A pathology test that applies artificial intelligence (AI) to characterize tissue samples can accurately predict clinically significant prostate cancer disease progression following …

  8. Oncology (Cancer) Health Information | Mount Sinai - New York

    Oncology is the diagnosis and treatment of cancer. Typically, cancer treatment encompasses some combination of surgery, chemotherapy, radiation treatment, and hormone therapy.

  9. Treatments | Mount Sinai - New York

    We use the Gleason Score grading system to determine appropriate treatment options based on how aggressive your cancer is. The higher the score, the more quickly the cancer will grow. …

  10. Subcutaneous Talquetamab in Elderly Patients With Multiple …

    Dec 1, 2025 · - With a Gleason score of ≤6, treated within the last 24 months, or untreated and under surveillance - With a Gleason score of 3+4 that has been treated >6 months prior to full …